Merck, 1294036-2X2.94MG, rGlucagon, recombinant glucagon (human)

General description

Recombinant glucagon (rGlucagon) is a synthetic version of human glucagon produced via recombinant DNA technology. It is used for treating severe hypoglycemia and for diagnostic purposes. The USP standard enables potency, identity, and impurity testing of recombinant glucagon preparations.

The USP biologics peptides category encompasses a diverse range of therapeutic peptides that are essential in managing various medical conditions. These peptides, typically consisting of amino acid sequences of 40 residues or less, are critical for the development of high-quality medicines. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of peptide therapeutics throughout their lifecycle.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application
rGlucagon, recombinant glucagon (human) USP reference standard suitable for use in specified USP compendial tests and assays.

Also used to prepare standard digest, system suitability, and standard solution during the assay and identification of Glucagon and Glucagon for Injection, according to the monographs of United States Pharmacopeia (USP).
Other Notes
H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH.xHCl
Sales restrictions may apply.
This product is part of the USP Biologics program.